NEB and Mammoth Biosciences launch MB-CasFire enzyme for one-pot isothermal assays
NEB will manufacture and globally distribute Mammoth Biosciences' proprietary MB-CasFire enzyme, a thermostable Type V CRISPR nuclease that works across 37-65 °C and can be coupled directly with LAMP, RPA and NEAR assays. MB-CasFire resolves targets at single-nucleotide resolution and simplifies assay architecture by eliminating the need for multiple temperature incubations or component additions.
Primary source
Company press release (PR Newswire), November 10, 2026
New England Biolabs® and Mammoth Biosciences® Announce Global Licensing Agreement and Commercial Launch of MB-CasFire™ to Accelerate Isothermal Amplification-Based Assay Development
Machine-summarized from the source above; not independently reported. How we use automation